Nasopharyngeal carriage rate of Streptococcus pneumoniae in children with sickle cell disease before and after the introduction of heptavalent pneumococcal conjugate vaccine

Journal of Infection and Public Health

Volumn 1, Issue 1, 2008, Pages 40-44

  Alexander, Ellie ^a   Telfer, Paul ^b   Rashid, Harunor ^a   Ali, Kamal A ^a   Booy, Robert ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Nasopharyngeal carriage; Penicillin susceptibility; Pneumococcal conjugate vaccine; Sickle cell disease; Streptococcus pneumoniae

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; HEALTH CENTER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; NOSE SMEAR; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SICKLE CELL ANEMIA; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION;

ANEMIA, SICKLE CELL; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INFANT; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 63549148572     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2008.08.005     Document Type: Article

References (27)

1. Zarkowsky H.S., Gallagher D., Gill F.M., et al. Bacteremia in sickle hemoglobinopathies. J Pediatr 109 (1986) 579-585
2. Davies E.G., Riddington C., Lottenberg R., and Dower N. Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev 1 (2004) CD003885
3. Adamkiewicz T.V., Sarnaik S., Buchanan G.R., et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 143 (2003) 438-444
4. Peltola H., Booy R., and Schmitt H.J. What can children gain from pneumococcal conjugate vaccines?. Eur J Pediatr 163 (2004) 509-516
5. Bjornson A.B., Falletta J.M., Verter J.I., et al. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis. J Pediatr 129 (1996) 828-835
6. Finn A., Booy R., Moxon R., Sharland M., and Heath P. Should the new pneumococcal vaccine be used in high-risk children?. Arch Dis Child 87 (2002) 18-21
7. Gaston M.H., Verter J.I., Woods G., et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 314 (1986) 1593-1599
8. Hofmann J., Cetron M.S., Farley M.M., et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 333 (1995) 481-486
9. O'Brien K.L., Swift A.J., Winkelstein J.A., et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics 106 (2000) 965-972
10. Nowak-Wegrzyn A., Winkelstein J.A., Swift A.J., and Lederman H.M. Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group. Clin Diagn Lab Immunol 7 (2000) 788-793
11. Pai V.B., Heyneman C.A., and Erramouspe J. Conjugated heptavalent pneumococcal vaccine. Ann Pharmacother 36 (2002) 1403-1413
12. Vernacchio L., Neufeld E.J., MacDonald K., et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 133 (1998) 275-278
13. Whitney C.G., Farley M.M., Hadler J., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
14. Telfer P., Coen P., Chakravorty S., et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica 92 (2007) 905-912
15. Fey P. New NCCLS interpretive Standards for Streptococcus pneumoniae. Available from http://www.nphl.org/documents/NewNCCLSInterpretiveStandardsForStreptococcuspnewumoniae-Fey.pdf [accessed August 19, 2008].
16. Anglin D.L., Siegel J.D., Pacini D.L., Smith S.J., Adams G., and Buchanan G.R. Effect of penicillin prophylaxis on nasopharyngeal colonization with Streptococcus pneumoniae in children with sickle cell anemia. J Pediatr 104 (1984) 18-22
17. Dunais B., Carsenti-Dellamonica H., Bruno P., et al. Mode de garde et portage naso-pharyngé de S. pneumoniae et H. influenzae d'enfants dans les Alpes-Maritimes. Presse Med 33 (2004) 1425-1430
18. Regev-Yochay G., Raz M., Dagan R., et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 38 (2004) 632-639
19. Steele R.W., Warrier R., Unkel P.J., et al. Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease. J Pediatr 128 (1996) 531-535
20. Lakshman R., Murdoch C., Race G., Burkinshaw R., Shaw L., and Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child 88 (2003) 211-214
21. Grivea I.N., Panagiotou M., Tsantouli A.G., and Syrogiannopoulos G.A. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Pediatr Infect Dis J 27 (2008) 519-525
22. Adamkiewicz T.V., Silk B.J., Howgate J., et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics 121 (2008) 562-569
23. Halasa N.B., Shankar S.M., Talbot T.R., et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44 (2007) 1428-1433
24. Martens P., Worm S.W., Lundgren B., Konradsen H.B., and Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 4 (2004) 21
25. Bogaert D., Veenhoven R.H., Sluijter M., et al. Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis media. J Clin Microbiol 43 (2005) 74-83
26. Choo S., and Finn A. New pneumococcal vaccines for children. Arch Dis Child 84 (2001) 289-294
27. Madhi S.A., Levine O.S., Hajjeh R., Mansoor O.D., and Cherian T. Vaccines to prevent pneumonia and improve child survival. Bull World Health Organ 86 (2008) 365-372